Mucopolysaccharidosis (MPS)
Rare Disease·MeSH: Mucopolysaccharidoses
Prevalence
5.0 / 100K
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Frequently asked questions
How many drugs are in development for Mucopolysaccharidosis (MPS)?
BioSniper tracks 2 drugs in development for Mucopolysaccharidosis (MPS) across 2 companies.
How many clinical trials target Mucopolysaccharidosis (MPS)?
There are 1 clinical trial targeting Mucopolysaccharidosis (MPS) tracked by BioSniper.
What is the prevalence of Mucopolysaccharidosis (MPS)?
The estimated prevalence of Mucopolysaccharidosis (MPS) is approximately 5.0 per 100,000 population.
Deep-dive into Mucopolysaccharidosis (MPS)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis